| Literature DB >> 16997550 |
Stephen J Baker1, Tsutomu Akama, Yong-Kang Zhang, Vittorio Sauro, Chetan Pandit, Rajeshwar Singh, Maureen Kully, Jehangir Khan, Jacob J Plattner, Stephen J Benkovic, Ving Lee, Kirk R Maples.
Abstract
A series of borinic acid picolinate esters were synthesized and screened for their minimum inhibitory concentration (MIC) against Gram-positive and -negative bacteria. Our lead compounds were then screened for anti-inflammatory activity. From these studies, we identified 3-hydroxypyridine-2-carbonyloxy-bis(3-chloro-4-methylphenyl)borane (2g, AN0128) as having the best combination of anti-bacterial and anti-inflammatory activities. This compound is now in clinical development for dermatological conditions.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16997550 DOI: 10.1016/j.bmcl.2006.08.130
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823